CH668911C1 - Injizierbare gebrauchsfertige Lösungen, die ein Anthracyclinglycosid mit Antitumorwirkung enthalten. - Google Patents

Injizierbare gebrauchsfertige Lösungen, die ein Anthracyclinglycosid mit Antitumorwirkung enthalten. Download PDF

Info

Publication number
CH668911C1
CH668911C1 CH2534/86A CH253486A CH668911C1 CH 668911 C1 CH668911 C1 CH 668911C1 CH 2534/86 A CH2534/86 A CH 2534/86A CH 253486 A CH253486 A CH 253486A CH 668911 C1 CH668911 C1 CH 668911C1
Authority
CH
Switzerland
Prior art keywords
acid
injectable solutions
antitumor activity
use containing
solutions ready
Prior art date
Application number
CH2534/86A
Other languages
German (de)
English (en)
Other versions
CH668911A5 (de
Inventor
Gaetano Gatti
Diego Oldani
Giuseppe Bottoni
Carlo Confalonieri
Luciano Gambini
Ponti Roberto De
Original Assignee
Pharmacia & Upjohn S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10583216&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CH668911(C1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn S.P.A. filed Critical Pharmacia & Upjohn S.P.A.
Publication of CH668911A5 publication Critical patent/CH668911A5/de
Publication of CH668911C1 publication Critical patent/CH668911C1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
CH2534/86A 1985-08-02 1986-06-24 Injizierbare gebrauchsfertige Lösungen, die ein Anthracyclinglycosid mit Antitumorwirkung enthalten. CH668911C1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858519452A GB8519452D0 (en) 1985-08-02 1985-08-02 Injectable solutions

Publications (2)

Publication Number Publication Date
CH668911A5 CH668911A5 (de) 1989-02-15
CH668911C1 true CH668911C1 (de) 2000-05-31

Family

ID=10583216

Family Applications (2)

Application Number Title Priority Date Filing Date
CH02158/99A CH690490C2 (de) 1985-08-02 1986-06-24 Anthracyclinglycosidlösung.
CH2534/86A CH668911C1 (de) 1985-08-02 1986-06-24 Injizierbare gebrauchsfertige Lösungen, die ein Anthracyclinglycosid mit Antitumorwirkung enthalten.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH02158/99A CH690490C2 (de) 1985-08-02 1986-06-24 Anthracyclinglycosidlösung.

Country Status (34)

Country Link
US (1) US4946831A (ja)
JP (1) JPH0655667B2 (ja)
KR (1) KR920001773B1 (ja)
CN (1) CN1064531C (ja)
AT (1) AT397463B (ja)
BE (1) BE905202A (ja)
BG (1) BG60425B2 (ja)
CA (1) CA1291037C (ja)
CH (2) CH690490C2 (ja)
CS (1) CS277561B6 (ja)
CY (1) CY1592A (ja)
DE (1) DE3621844C2 (ja)
DK (1) DK167557B1 (ja)
ES (1) ES8801580A1 (ja)
FI (1) FI86800C (ja)
FR (1) FR2585569B1 (ja)
GB (2) GB8519452D0 (ja)
GR (1) GR861556B (ja)
HK (1) HK93990A (ja)
HU (1) HU196123B (ja)
IE (1) IE59297B1 (ja)
IL (1) IL79129A (ja)
IT (1) IT1204906B (ja)
NL (2) NL191507C (ja)
NO (1) NO170913C (ja)
NZ (1) NZ216604A (ja)
PH (1) PH22332A (ja)
PT (1) PT82865B (ja)
RU (2) RU1837883C (ja)
SE (1) SE466383C (ja)
SG (1) SG80690G (ja)
UA (1) UA29383C2 (ja)
YU (1) YU44788B (ja)
ZA (1) ZA864792B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977082A (en) 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124317A (en) 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
EP1283044A3 (en) * 1986-12-05 2003-05-14 Pharmacia Italia S.p.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
FI883337A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Icke-vattenloesningar av doxorubicinhydroklorin.
FI883338A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.
DE3801178A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
DE68905577T2 (de) * 1988-12-05 1993-07-01 Bristol Myers Squibb Co Doxorubicin-loesungen.
FI895733A0 (fi) * 1988-12-05 1989-11-30 Bristol Myers Squibb Co Vattenloesningar av doxorubicin.
GB9200247D0 (en) * 1992-01-07 1992-02-26 Erba Carlo Spa Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
DE19544532C2 (de) * 1995-11-29 1997-12-11 Pharma Dynamics Gmbh Verfahren zum Herstellen eines Doxorubicin-Lyophilisats
ATE195526T1 (de) * 1996-12-16 2000-09-15 Pharmachemie Bv Verfahren zur herstellung von epirubicin oder zusatzsalzen davon, von daunorubicin
BR9713661A (pt) 1996-12-30 2000-10-24 Battelle Memorial Institute Formulação e método para o tratamento de neoplasmas por inalação
US20090253220A1 (en) * 2003-10-28 2009-10-08 Sukanta Banerjee Absorbing Biomolecules into Gel-Shell Beads
CA2606390A1 (en) * 2005-05-11 2006-11-16 Sicor, Inc. Stable lyophilized anthracycline glycosides
US20140378404A1 (en) * 2011-10-25 2014-12-25 Nektar Therapeutics Treatment of Patients Suffering from Cancer
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
GB1457632A (en) * 1974-03-22 1976-12-08 Farmaceutici Italia Adriamycins
GB1500421A (en) * 1975-01-22 1978-02-08 Farmaceutici Italia Optically active anthracyclinones
US4039663A (en) * 1975-03-19 1977-08-02 Societa' Farmaceutici Italia S.P.A. Daunomycins, process for their uses and intermediates
FR2314726A1 (fr) * 1975-06-16 1977-01-14 Rhone Poulenc Ind Nouveaux derives du naphtagene, leur preparation et les compositions qui les contiennent
GB1511559A (en) * 1975-09-26 1978-05-24 Farmaceutici Italia Anthracycline glycosides
FR2397425A1 (fr) * 1977-07-11 1979-02-09 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
DE2738656A1 (de) * 1977-08-26 1979-03-08 Microbial Chem Res Found Anthracyclinglycoside, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
FR2430425A1 (fr) * 1978-07-07 1980-02-01 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2433027A1 (fr) * 1978-08-08 1980-03-07 Rhone Poulenc Ind Nouveau procede de preparation de derives de la doxorubicine
US4325947A (en) * 1981-05-12 1982-04-20 Farmitalia Carlo Erba S.P.A. 4-Demethoxy-4'-deoxydoxorubicin
US4438105A (en) * 1982-04-19 1984-03-20 Farmaitalia Carlo Erba S.P.A 4'-Iododerivatives of anthracycline glycosides
US4464529A (en) * 1982-07-20 1984-08-07 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
JPS6092212A (ja) * 1983-10-26 1985-05-23 Kyowa Hakko Kogyo Co Ltd ドキソルビシン塩の製剤
EP1283044A3 (en) * 1986-12-05 2003-05-14 Pharmacia Italia S.p.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

Also Published As

Publication number Publication date
US4946831A (en) 1990-08-07
CS277561B6 (en) 1993-03-17
JPH0655667B2 (ja) 1994-07-27
IT8620917A0 (it) 1986-06-26
CH690490C2 (de) 2000-09-29
FR2585569A1 (fr) 1987-02-06
AT397463B (de) 1994-04-25
CY1592A (en) 1992-04-03
NO170913C (no) 2003-10-10
DE3621844A1 (de) 1987-03-05
RU2110263C1 (ru) 1998-05-10
SE466383B (sv) 1992-02-10
FI862629A0 (fi) 1986-06-19
SE466383C (sv) 1995-10-19
KR870001828A (ko) 1987-03-28
NO862587L (no) 1987-02-03
BE905202A (fr) 1987-02-02
ATA176886A (de) 1993-09-15
CA1291037C (en) 1991-10-22
YU44788B (en) 1991-02-28
CS470886A3 (en) 1992-11-18
BG60425B2 (bg) 1995-03-31
GB8519452D0 (en) 1985-09-11
PT82865B (pt) 1989-01-17
GB2178311A (en) 1987-02-11
NL300011I1 (nl) 2000-10-02
SG80690G (en) 1990-11-23
HU196123B (en) 1988-10-28
IL79129A0 (en) 1986-09-30
NO862587D0 (no) 1986-06-26
RU1837883C (ru) 1993-08-30
NL191507B (nl) 1995-04-18
IE861598L (en) 1987-02-02
SE8602743D0 (sv) 1986-06-19
NZ216604A (en) 1989-10-27
IL79129A (en) 1992-03-29
IT1204906B (it) 1989-03-10
FI862629A (fi) 1987-02-03
HK93990A (en) 1990-11-23
NL191507C (nl) 2000-02-16
FR2585569B1 (fr) 1990-01-19
DK167557B1 (da) 1993-11-22
AU5885886A (en) 1987-02-12
GB8614800D0 (en) 1986-07-23
ES556291A0 (es) 1988-02-16
ZA864792B (en) 1988-02-24
ES8801580A1 (es) 1988-02-16
AU598197B2 (en) 1990-06-21
CH668911A5 (de) 1989-02-15
DE3621844C2 (de) 1994-02-17
HUT42326A (en) 1987-07-28
NL8601698A (nl) 1987-03-02
PT82865A (en) 1986-07-01
KR920001773B1 (ko) 1992-03-02
UA29383C2 (uk) 2000-11-15
GB2178311B (en) 1989-10-11
CN1064531C (zh) 2001-04-18
DK306286A (da) 1987-02-03
YU103586A (en) 1988-04-30
FI86800C (fi) 1999-10-28
SE8602743L (sv) 1987-02-03
GR861556B (en) 1986-10-17
DK306286D0 (da) 1986-06-27
PH22332A (en) 1988-07-29
IE59297B1 (en) 1994-02-09
NO170913B (no) 1992-09-21
CN86104283A (zh) 1987-01-28
JPS6248629A (ja) 1987-03-03
FI86800B (fi) 1992-07-15

Similar Documents

Publication Publication Date Title
CH668911C1 (de) Injizierbare gebrauchsfertige Lösungen, die ein Anthracyclinglycosid mit Antitumorwirkung enthalten.
DE2727150A1 (de) Praeparat zur erhoeung des ph-wertes
EP0166856A1 (de) Isoliermittel
KR970073403A (ko) 헛개나무 추출물을 함유하는 음료 조성물과 이의 제조방법
CH632164A5 (de) Verfahren zur herstellung einer stabilen thymosinfraktion 5 und so erhaltene thymosinfraktion 5.
CA2072693A1 (en) Aqueous two-component polyurethane-forming compositions and a process for their preparation
EP0209854A3 (de) Pyridinderivate und deren Verwendung als fungizide Wirkstoffe
DE1492185A1 (de) Desinfektionsmittel zur Verhinderung von Karies
EP0100447A2 (de) Kosmetisches Mittel von haarregenerierender Wirkung
CH455146A (de) Verfahren zur Herstellung von Diphtherie-Toxoiden
US4906660A (en) Wood preservative composition and method
DE2454364A1 (de) Cobalaminderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
Sander et al. Induction of malignant tumors in rats by oral administration of 2-imidazolidinone and nitrite
DE1617500C3 (de) Konservierung von Blutplasma
DE942534C (de) Verfahren zur Herstellung von haltbaren und gut wirksamen Loesungen oder Suspensionen antibiotischer Mittel
DE932083C (de) Verfahren zur Herstellung stabiler waessriger Injektionsloesungen von 2-Methyl-5, 8-dimethoxy-furanochromon
AT210567B (de) Verfahren zum Stabilisieren einer wässerigen Lösung von Pflanzenextrakten, insbesondere herzwirksamen Pflanzenextrakten
AT232194B (de) Verfahren zur Herstellung eines Toxoids, insbesondere eines Diphtherie-Toxoids, aus einem gereinigten Bakterientoxin
DE537988C (de) Mittel zur Beseitigung und zur Verhuetung der Bildung von Kesselstein
DE904652C (de) Verfahren zur Herstellung konzentrierter, haltbarer waessriger Loesungen von Furanochromonen
DE968534C (de) Verfahren zur Herstellung von wasserloeslichen Pulvern, Tabletten und waessrigen Loesungen schwerloeslicher Salze des 1-(3, 4-Dimethoxybenzyl)-6, 7-dimethoxyisochinolinsoder 1-Benzyl-3-aethyl-6, 7-dimethoxyisochinolins
DE586514C (de) Verfahren zur Darstellung von Verbindungen des Coffeins mit Calcium- und Strontiumrhodanid
Takeuchi ÜBER DEN EINFLUSS VERSCHIEDENER ORGANI-SCHER VERBINDUNGEN AUF DIE UREASE
CH360069A (de) Verfahren zur Herstellung von Oxymethylamino-Verbindungen
DE858552C (de) Verfahren zur Herstellung von quaternaeren Verbindungen

Legal Events

Date Code Title Description
AEN Modification of the scope of the patent
PUE Assignment

Owner name: PHARMACIA S.P.A.

PFA Name/firm changed

Owner name: PHARMACIA S.P.A. TRANSFER- PHARMACIA & UPJOHN S.P.

NV New agent

Representative=s name: RITSCHER & SEIFERT PATENTANWAELTE VSP

AEN Modification of the scope of the patent

Free format text: VERZICHTSERKLAERUNG EINGEREICHT 05.08.1999VERZICHTSERKLAERUNG VEROEFFENTLICHT: 31.05.2000

SPCC Certificates - corrections

Free format text: IKS-NR. 54670/16.09.1998, 02.02.1999

NV New agent

Representative=s name: A. BRAUN, BRAUN, HERITIER, ESCHMANN AG PATENTANWAE

PUE Assignment

Owner name: PHARMACIA & UPJOHN S.P.A. TRANSFER- PHARMACIA ITAL

PL Patent ceased
SPCL Supplementary protection certificate deletion

Spc suppl protection certif: C668911/01